Skip to main content
Fig. 3 | Journal of Inflammation

Fig. 3

From: Protective and curative effects of unconjugated bilirubin on gene expression of LOX-1 and iNOS in the heart of rats receiving high-fat diet and low dose streptozotocin: a histomorphometric approach

Fig. 3

Body weight changes of the rats during 14 weeks of treatment. Based on two-way repeated measures ANOVA analysis, there was a significant interaction between the effect of treatment and the time on body weight. Values are expressed as mean ± SD (n = 6). Control = Normal rats; Bilirubin = Healthy rats received bilirubin; AS = Atherosclerosis model; AS + BR-6 (a.k.a. Treated group) = Atherosclerosis model received HFD + STZ + bilirubin (for 6 weeks); AS + BR-14 = Atherosclerosis model received HFD + STZ + bilirubin (for 14 weeks) (a.k.a. Protected group). * The control vs. other groups. *, **, *** and **** indicate p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us